Treatment of Recurrent Ischemic Stroke in Chronic CVA Patients
Acute Reperfusion Therapy: The Foundation of Modern Treatment
For a chronic CVA patient experiencing a second ischemic stroke, immediate intravenous rtPA (0.9 mg/kg) should be administered within 3 hours of symptom onset if eligible, followed by mechanical thrombectomy with stent retrievers for large vessel occlusions—this combined approach represents the most significant advancement in acute stroke treatment. 1, 2
Intravenous Thrombolysis
- Administer IV rtPA within 3 hours of clearly defined symptom onset (Class I, Level A evidence), with the treatment window potentially extending to 4.5 hours in carefully selected patients 1, 3
- The presence of prior stroke is not an absolute contraindication to rtPA unless it occurred within the previous 3 months 1
- Time is critical: every 30-minute delay in recanalization decreases the chance of good outcome by 8-14% 2
- Target door-to-needle time of <60 minutes to maximize functional outcomes 2, 4
Mechanical Thrombectomy: The Game-Changer
Stent retrievers (Solitaire FR and Trevo) are strongly preferred over older coil retrievers like Merci (Class I, Level A evidence) and should be deployed for proximal large vessel occlusions 1, 2
- Proceed directly to endovascular thrombectomy without waiting to assess clinical response to IV rtPA—this is a critical change from older practice patterns (Class III recommendation against waiting) 1, 2
- Indicated for patients with:
- Target door-to-groin puncture time of <110 minutes 2, 4
- Combined approach using stent retrievers and aspiration techniques achieves faster and more complete reperfusion (TICI 2b/3 in 59-87.8% of cases) 1, 2, 4
Intra-arterial Thrombolysis
- Remains an option for carefully selected patients with major stroke of <6 hours duration caused by MCA occlusions who are not candidates for IV rtPA 1
- However, mechanical thrombectomy with stent retrievers has largely superseded intra-arterial thrombolysis alone due to superior recanalization rates 1, 2
- Requires immediate access to cerebral angiography and experienced interventionalists 1
Secondary Prevention: Preventing the Third Stroke
Antiplatelet Therapy
Aspirin should be administered within 24-48 hours after stroke onset, but must be delayed for 24 hours in patients who received thrombolytic therapy 2, 3
For long-term secondary prevention in noncardioembolic stroke:
- The combination of aspirin 25 mg and extended-release dipyridamole 200 mg twice daily is preferred over aspirin alone (Grade 1A recommendation) 3
- Clopidogrel 75 mg daily is suggested over aspirin alone (Grade 2B recommendation) 3
- Avoid long-term combination of aspirin and clopidogrel (Grade 1B recommendation against) 3
Anticoagulation for Cardioembolic Stroke
For patients with atrial fibrillation and recurrent stroke, long-term oral anticoagulation with target INR 2.5 (range 2.0-3.0) is strongly recommended (Grade 1A) 3
- Rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily reduces the composite risk of stroke, MI, and cardiovascular death (HR 0.74,95% CI 0.65-0.86) in patients with coronary artery disease or peripheral artery disease 5
- This combination is particularly relevant for patients with both cerebrovascular and coronary disease 5
Blood Pressure Management: A Critical Balance
Maintain blood pressure ≤180/105 mmHg during and for 24 hours after mechanical thrombectomy or thrombolytic therapy 1, 2, 4
- Avoid aggressive blood pressure lowering in acute ischemic stroke unless BP exceeds 220/120 mmHg in patients not receiving thrombolysis 1, 6
- For patients eligible for thrombolysis, BP must be reduced to <185/110 mmHg before treatment 1
- Use labetalol 10-20 mg IV over 1-2 minutes or nicardipine infusion for BP control 1
Advanced Imaging: Selecting the Right Patients
CT angiography with source images (CTA-SI) should be performed along with vascular imaging and perfusion studies, particularly if mechanical thrombectomy is contemplated (Class I, Level A) 1
- The presence of cerebral microbleeds on MRI is not an absolute contraindication to IV tPA if there are only a small number (<5 microbleeds) (Class IIa, Level B) 1
- The risk with multiple microbleeds (>5) is uncertain and requires careful consideration 1
Common Pitfalls and Critical Caveats
Time-Related Errors
- Never delay transfer to an endovascular-capable center for extensive diagnostic workup—establish rapid transfer protocols 2, 6
- Do not wait to assess clinical response to IV rtPA before pursuing endovascular therapy—this outdated practice worsens outcomes 1, 2
Hemorrhagic Risk Management
- Symptomatic hemorrhage risk increases 8-fold with early edema or mass effect on CT after rtPA 4
- Monitor closely for hemorrhagic transformation, especially in patients requiring anticoagulation for atrial fibrillation 2
Reocclusion Risk
- Approximately one-third of patients develop reocclusion after IV thrombolysis, particularly those with partial recanalization 1
- This necessitates intensive monitoring in specialized stroke units with capabilities for managing post-thrombectomy patients 1, 2
Special Considerations for Recurrent Stroke
- Prior stroke is not a contraindication to acute reperfusion therapy unless it occurred within 3 months 1
- Patients with recurrent stroke often have multiple vascular risk factors requiring aggressive secondary prevention 7
- Dyslipidemia, atrial fibrillation, and obesity are significantly associated with recurrent CVA in elderly patients and require targeted management 7
Post-Procedure Monitoring
Intensive monitoring protocols must be implemented with vital signs and neurological checks every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours after thrombectomy 1